UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 13, 2006
Micrus Endovascular Corporation
(Exact name of registrant as specified in its charter)
000-51323
(Commission File Number)
| |
|
|
| Delaware
|
|
23-2853441 |
| (State or Other Jurisdiction of
|
|
(I.R.S. Employer Identification No.) |
| Incorporation) |
|
|
821 Fox Lane
San Jose, California 95131
(Address of principal executive offices, including zip code)
(408) 433-1400
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02. Results of Operations and Financial Condition.
On November 13, 2006, Micrus Endovascular Corporation (“Micrus”) issued a press release,
reporting its financial results for the fiscal quarter ended September 30, 2006. A copy of this
earnings release is attached as Exhibit 99.1 hereto. Following the issuance of this earnings
release, Micrus hosted an earnings call in which its financial results for the fiscal quarter ended
September 30, 2006 were discussed.
Exhibit 99.1 contains forward-looking statements within the meaning of the federal securities
laws. These statements are present expectations, and are subject to the limitations listed therein
and in Micrus’ other SEC reports, including that actual events or results may differ materially
from those in the forward-looking statements.
The foregoing information (including the exhibit hereto) is being furnished under “Item 2.02
Results of Operations and Financial Condition” (including the exhibit hereto) and shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor
shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| |
|
|
| Exhibit |
|
Description |
99.1
|
|
Press Release dated November 13, 2006 |
-1-